Identification of a CSF- and blood biomarker fingerprint differentiating between highly active and moderate/mild forms of multiple sclerosis (MS)

Identification of a CSF- and blood biomarker fingerprint differentiating between highly active and moderate/mild forms of multiple sclerosis (MS) - Biomarker Fingerprint MS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015761

Enrollment

200

Registered

2018-11-13

Start date

2016-03-31

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G35

Interventions

Group 1: Samples taken during diagnostic work-up. No further study-related interventions.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with highly active and moderately/mildly active forms of multiple sclerosis

Exclusion criteria

Exclusion criteria: Patients less than 18 years old.

Design outcomes

Primary

Measure	Time frame
Differentiation between highly active and moderate/mild forms of multiple sclerosis. A hypothesis-free and a hypothesis-driven approach will be applied.	—

Secondary

Measure	Time frame
Initial therapeutic decision	—

Countries

Germany

Contacts

Public ContactChristian Förch

Klinikum der Johann Wolfgang Goethe-Universität Zentrum der Neurologie und Neurochirurgie

foerch@em.uni-frankfurt.de069-6301 6395

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026